Hi All,
Will Stanelco and Carlco licence their non-RF Capsule technology to Isracaps ?
Isracaps are alive and kicking, this guy works for Isracaps public relations company, and he would hardly put Isracaps on his CV if the publicity failed, and his email even appears in the announcement below .... and I have sent him a few questions :)
http://www.tallyelhyani.com/ResumeTxt.asp
Experience
Koteret Public Relations, Director International Public Relations (MS&L & Ketchem affiliate) Sep 2003 present
Israels premier B2B public relations agency currently employs 25 employees. Responsibilities include: New Business bringing in new projects, account management, strategic planning, determination and execution of tactics and campaigns. Trade analyst relations. Projects: Trivnet (M-Commerce), Corner Shot (Defense), Isracaps (Pharmaceutical), Vitalife (Biotech VC), Teledata Networks (Telecom), ECI Telecom, Taglit birthright israel and Werbner & Sayles (Law Firm).
http://www.koteret.com/main/siteNew/index.php
(BW) Redazione economica TEL AVIV, Israel--(BUSINESS WIRE)-23 Ottobre, 2003--Isracaps Ltd, societ con sede in Israele, ha siglato un accordo di licenza con la britannica Stanelco Plc., (LSE: SEO) per la produzione e la distribuzione in Israele di capsule a base di amido. This new, internationally patented, revolutionary manufacturing process, enables the manufacture of starch capsules in which drugs, vitamins, food additives and other substances can be preserved in liquid form. The current solution for encapsulation is manufactured in a gelatine format, which limits the substance forms that can be encapsulated, is a longer process and therefore around 40% higher in cost. It also cannot easily control the amount of time it takes for the content of the capsule to be absorbed into the bloodstream. This agreement will allow Isracaps to manufacture capsules for encapsulation of prescription and non-prescription drugs, vitamins, food additives, cosmetics and other substances. This agreement has firmly positioned Isracaps as the sole player in Israel with the capacity to manufacture starch based capsules using Stanelco's patented technology. Yaron Berenholtz, CEO and co-founder of Isracaps commented: 'This is one of the most exciting events to take place in the drug, vitamin and food additives markets in recent years. Presently, less than half the range of available drugs can be packaged in gelatine capsules due to the interaction with the gelatine. The introduction of capsules made from starch, derived from plant sources, using a new manufacturing technology, will open up the drug capsules market and drastically reduce costs.' 'We are very excited about the agreement with Isracaps,' said Barrie Hozier, Finance Director for Stanelco Plc. 'We expect that starch capsules will displace most of the existing gelatine capsules from the capsule market to become the new standard in capsules. We estimate that the combined segment value totals over a billion dollars, with the pharmaceutical segment representing a significant share of this market.' Isracaps is currently in talks with pharmaceutical companies and institutional financial investors, with a view to raising funds and signing a strategic cooperation agreement. It is also in the process of setting up manufacturing facilities in Israel and recruiting initial staff. About Isracaps Isracaps is an Israel based company, which was founded specifically for the purpose of winning this licence from Stanelco. The company will be managed by businessmen Ben White and Yaron Bernholz and will focus on the manufacture and marketing of starch capsules. About Stanelco Founded in 1953, Stanelco (LSE:SEO) is traded on the London Stock Exchange and is a world leader in the design and manufacture of fibre furnace technology, induction heating and dielectric welding equipment. The company's core business is the manufacture of optic fibres using RF sealing technology. CONTACT: Tally Elhyani, +972.3561.1424 ext. 152 or +972.54.970.346 tally_e@koteret.com KEYWORD: ISRAEL UNITED KINGDOM INTERNATIONAL AFRICA/MIDDLE EAST EUROPE INDUSTRY KEYWORD: RETAIL FOODS/BEVERAGES MANUFACTURING MEDICAL PHARMACEUTICAL MARKETING AGREEMENTS PRODUCT SOURCE: Isracaps Ltd
Cheers,
PM